Moore Capital Management »

Dyne Therapeutics shares owned by Moore Capital Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 79k 18.13

More positions owned by Moore Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ally Financial (ALLY)
Bank of America Corporation (BAC)
Ubs Group SHS (UBS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Apollo Global Mgmt (APO)
Coinbase Global Note 0.500% 6/0 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Etsy Note 0.125%10/0 (Principal)
Global Payments (GPN)
Fidelity National Information Services (FIS)

View all positions for Moore Capital Management

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
BlackRock
Vanguard Group
Atlas Venture Life Science Advisors
Orbis Allan Gray
State Street Corporation
FMR
Vanguard Capital Management
Fcpm Iii Services B.v.
Adage Capital Partners GP
Perceptive Advisors
TCG Crossover Management
Vanguard Portfolio Management
Vestal Point Capital

View all funds holding Dyne Therapeutics